Shumoogam Jaya, Beecher Natasher
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK.
IDrugs. 2010 Feb;13(2):57-9.
The 51st American Society of Hematology (ASH) Annual Meeting and Exposition, held in New Orleans, included topics covering new therapeutic developments in the field of hematology. This conference report highlights selected presentations on hematological malignancies, lymphoma, Hodgkin lymphoma, AKT inhibitors for the treatment of chronic lymphocytic leukemia, and the activation of GPIb with von Willebrand factor. Investigational drugs discussed include conatumumab (Amgen Inc/Takeda Bio Development Center Ltd) and A-443654 (Abbott Laboratories).
第51届美国血液学会（ASH）年会暨展览会在新奥尔良举行，涵盖了血液学领域新治疗进展的主题。本会议报告重点介绍了有关血液系统恶性肿瘤、淋巴瘤、霍奇金淋巴瘤、用于治疗慢性淋巴细胞白血病的AKT抑制剂以及血管性血友病因子激活糖蛋白Ib的部分演讲。讨论的研究药物包括考那单抗（安进公司/武田生物开发中心有限公司）和A - 443654（雅培实验室）。
Zotero 插件